Amid the grim headlines, a landmark study published in The Lancet offered a powerful dose of hope. A population-level analysis from England found zero deaths from cervical cancer among women aged 20–24 during the period 2020–2024. These women belong to the first generation systematically offered HPV vaccination at school age.
Greek pediatricians amplified the findings, issuing a clear message: “HPV vaccination is vaccination against cancer. It applies to girls and boys, protects their future health, and can save lives.” The data represents one of the most compelling real-world demonstrations that a vaccine can effectively eliminate a type of cancer death in a cohort — a result that health advocates hope will boost uptake worldwide.
The good news on cancer extended to India, where Assam’s Health Minister told the state assembly that the northeastern state has recorded the country’s highest cancer survival rate at 62%, attributing the success to a decentralized care model and large-scale early detection programs.
